Sarasota, Florida
Phase 1 cancer trials in Sarasota, FL
45 Phase 1 cancer studies are recruiting participants at sites in Sarasota as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Sarasota at a glance
- 45 studies are recruiting at a site in Sarasota.
- By phase: Phase 1 (32), Phase 1/2 (13).
- By sponsor: industry (44), university, hospital or other (1).
- By research area: Breast Cancer (18), Lung Cancer (14), Prostate Cancer (7), Lymphoma (4), Melanoma (1), Pancreatic Cancer (1).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Sarasota
Basic details from each study's public record (the 30 most recently updated of 45). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- Florida Cancer Specialists & Research Institute (FCS) - Sarasota
- Registry record
- NCT06638307 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07503808 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- SCRI Florida Cancer Specialists - Sarasota
- Registry record
- NCT07029399 · updated
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Compass Therapeutics
- Study site
- Florida Cancer Specialists - Sarasota
- Registry record
- NCT06150664 · updated
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07524855 · updated
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Immunome, Inc.
- Study site
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen
- Registry record
- NCT07578571 · updated
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Florida Cancer Specialists- Sarasota Cattlemen /ID# 261569
- Registry record
- NCT06084481 · updated
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Accent Therapeutics
- Study site
- Florida Cancer Specialists
- Registry record
- NCT06799065 · updated
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Olema Oncology, Inc.
- Study site
- Florida Cancer Specialists
- Registry record
- NCT06784193 · updated
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Avacta Life Sciences Ltd
- Study site
- Florida Cancer Specialists and Research Institute
- Registry record
- NCT07454642 · updated
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT05867251 · updated
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Angiex, Inc.
- Study site
- Florida Cancer Specialist
- Registry record
- NCT06440005 · updated
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
- Phase 1
- Ages 21 and older
- All sexes
- Sponsor
- MBQ Pharma
- Study site
- Florida Cancer Specialists / Sarah Cannon Research Institute / SCRI
- Registry record
- NCT06075810 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- Florida Cancer Specalists
- Registry record
- NCT06983743 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07458347 · updated
SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Florida Cancer Specialists Sarasota
- Registry record
- NCT07857616 · updated
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT06179069 · updated
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT07038343 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Florida Cancer Specialists
- Registry record
- NCT06026410 · updated
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07070232 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Florida Cancer Specialists
- Registry record
- NCT06128551 · updated
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Blueprint Medicines Corporation
- Study site
- Florida Cancer Specialists & Research Institute - Sarasota
- Registry record
- NCT07629960 · updated
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- InduPro, Inc.
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07602842 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Sarasota
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists
- Registry record
- NCT05818683 · updated
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists
- Registry record
- NCT06800313 · updated
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07082920 · updated
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07319871 · updated
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Florida Cancer Specialists & Research Institute
- Registry record
- NCT07746713 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Sarasota, FL on ClinicalTrials.gov.
Melanoma studies recruiting in Sarasota
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Sarasota Memorial Hospital
- Registry record
- NCT05655312 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Sarasota, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Sarasota
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Florida Cancer Specialists - Sarasota
- Registry record
- NCT07226843 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Sarasota, FL on ClinicalTrials.gov.
Ask about studies near Sarasota
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
240 studies recruiting across 42 cities.
Tampa
74 studies recruiting.
Jacksonville
47 studies recruiting.
Miami
47 studies recruiting.
Orlando
41 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections